69 related articles for article (PubMed ID: 10073004)
1. [Expression of epidermal growth factor and its receptor in human primary hepatocellular carcinoma].
Wu X; Peng L
Hunan Yi Ke Da Xue Xue Bao; 1997; 22(6):544-6. PubMed ID: 10073004
[No Abstract] [Full Text] [Related]
2. Epidermal growth factor receptor expression and gene copy number in conventional hepatocellular carcinoma.
Buckley AF; Burgart LJ; Sahai V; Kakar S
Am J Clin Pathol; 2008 Feb; 129(2):245-51. PubMed ID: 18208805
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor expression and gene copy number in fibrolamellar hepatocellular carcinoma.
Buckley AF; Burgart LJ; Kakar S
Hum Pathol; 2006 Apr; 37(4):410-4. PubMed ID: 16564914
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma.
El-Bassiouni A; Nosseir M; Zoheiry M; El-Ahwany E; Ghali A; El-Bassiouni N
APMIS; 2006 Jun; 114(6):420-7. PubMed ID: 16856963
[TBL] [Abstract][Full Text] [Related]
5. [Correlation between epidermal growth factor and overexpression of vascular endothelial growth factor in hepatocellular carcinoma].
Huang G; Yang L; Yang J; Liu H; Yang Z
Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):564-6. PubMed ID: 12667326
[TBL] [Abstract][Full Text] [Related]
6. Blockage of epidermal growth factor receptor by quinazoline tyrosine kinase inhibitors suppresses growth of human hepatocellular carcinoma.
Liu Y; Poon RT; Shao W; Sun X; Chen H; Kok TW; Fan ST
Cancer Lett; 2007 Apr; 248(1):32-40. PubMed ID: 16837130
[TBL] [Abstract][Full Text] [Related]
7. High aromatase activity and overexpression of epidermal growth factor receptor in fibrolamellar hepatocellular carcinoma in a child.
Muramori K; Taguchi S; Taguchi T; Kohashi K; Furuya K; Tokuda K; Ishii E
J Pediatr Hematol Oncol; 2011 Jul; 33(5):e195-7. PubMed ID: 21552145
[TBL] [Abstract][Full Text] [Related]
8. COX-2 expression in hepatocellular carcinoma is an initiation event; while EGF receptor expression with downstream pathway activation is a prognostic predictor of survival.
Foster J; Black J; LeVea C; Khoury T; Kuvshinoff B; Javle M; Gibbs JF
Ann Surg Oncol; 2007 Feb; 14(2):752-8. PubMed ID: 17146741
[TBL] [Abstract][Full Text] [Related]
9. Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness.
de la Monte SM; Tamaki S; Cantarini MC; Ince N; Wiedmann M; Carter JJ; Lahousse SA; Califano S; Maeda T; Ueno T; D'Errico A; Trevisani F; Wands JR
J Hepatol; 2006 May; 44(5):971-83. PubMed ID: 16564107
[TBL] [Abstract][Full Text] [Related]
10. Amphiregulin contributes to the transformed phenotype of human hepatocellular carcinoma cells.
Castillo J; Erroba E; PerugorrÃa MJ; SantamarÃa M; Lee DC; Prieto J; Avila MA; Berasain C
Cancer Res; 2006 Jun; 66(12):6129-38. PubMed ID: 16778186
[TBL] [Abstract][Full Text] [Related]
11. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of growth factor signaling in human hepatocellular carcinoma.
Breuhahn K; Longerich T; Schirmacher P
Oncogene; 2006 Jun; 25(27):3787-800. PubMed ID: 16799620
[TBL] [Abstract][Full Text] [Related]
13. The inhibitory effect of p75 neurotrophin receptor on growth of human hepatocellular carcinoma cells.
Yuanlong H; Haifeng J; Xiaoyin Z; Jialin S; Jie L; Li Y; Huahong X; Jiugang S; Yanglin P; Kaichun W; Jie D; Daiming F
Cancer Lett; 2008 Sep; 268(1):110-9. PubMed ID: 18462868
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma.
Ch'ng S; Low I; Ng D; Brasch H; Sullivan M; Davis P; Tan ST
Hum Pathol; 2008 Mar; 39(3):344-9. PubMed ID: 18045646
[TBL] [Abstract][Full Text] [Related]
15. [Expression of growth hormone receptor mRNA in hepatocellular carcinoma and matched para-cancer cirrhotic liver tissue].
Wang HT; Wang J; Ou QJ; Liu XP; Chen S
Ai Zheng; 2002 Feb; 21(2):146-8. PubMed ID: 12479063
[TBL] [Abstract][Full Text] [Related]
16. Expression of transforming growth factor-beta1 and transforming growth factor-beta receptors in hepatocellular carcinoma and dysplastic nodules.
Paik SY; Park YN; Kim H; Park C
Mod Pathol; 2003 Jan; 16(1):86-96. PubMed ID: 12527718
[TBL] [Abstract][Full Text] [Related]
17. [Studies on production of human epidermal growth factor and its receptor in human hepatoma cell line (PLC/PRF/5)].
Hase K
Nihon Shokakibyo Gakkai Zasshi; 1987 Jan; 84(1):128. PubMed ID: 3033358
[No Abstract] [Full Text] [Related]
18. New molecular targets for hepatocellular carcinoma: the ErbB1 signaling system.
Berasain C; Castillo J; Prieto J; Avila MA
Liver Int; 2007 Mar; 27(2):174-85. PubMed ID: 17311611
[TBL] [Abstract][Full Text] [Related]
19. Expression of hepatocyte growth factor activator and hepatocyte growth factor activator inhibitor type 1 in human hepatocellular carcinoma.
Nagata K; Hirono S; Ido A; Kataoka H; Moriuchi A; Shimomura T; Hori T; Hayashi K; Koono M; Kitamura N; Tsubouchi H
Biochem Biophys Res Commun; 2001 Nov; 289(1):205-11. PubMed ID: 11708800
[TBL] [Abstract][Full Text] [Related]
20. [The significance and promoter expression of insulin-like growth factor-II gene in human hepatocellular carcinoma].
Tang SH; Yang DH; Huang W; Zhou M; Zhou HK; Lu XH; Ye G
Zhonghua Gan Zang Bing Za Zhi; 2006 Jun; 14(6):456-8. PubMed ID: 16792873
[No Abstract] [Full Text] [Related]
[Next] [New Search]
